637 related articles for article (PubMed ID: 20966920)
1. The renin-angiotensin system and cancer: old dog, new tricks.
George AJ; Thomas WG; Hannan RD
Nat Rev Cancer; 2010 Nov; 10(11):745-59. PubMed ID: 20966920
[TBL] [Abstract][Full Text] [Related]
2. [Cancer and renin-angiotensin system].
Uemura H; Kubota Y
Nihon Rinsho; 2012 Sep; 70(9):1530-5. PubMed ID: 23012799
[TBL] [Abstract][Full Text] [Related]
3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
4. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li XC; Zhang J; Zhuo JL
Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
[TBL] [Abstract][Full Text] [Related]
5. Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues.
Borghi C; ; Rossi F;
High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):429-44. PubMed ID: 26403596
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the renin-angiotensin system.
Nicholls MG; Charles CJ; Crozier IG; Espiner EA; Ikram H; Rademaker MJ; Richards AM; Yandle TG
J Hypertens Suppl; 1994 Dec; 12(10):S95-103. PubMed ID: 7769497
[TBL] [Abstract][Full Text] [Related]
7. [The involvement of the renin-angiotensin system (RAS) in cancerogenesis].
Domińska K; Lachowicz-Ochedalska A
Postepy Biochem; 2008; 54(3):294-300. PubMed ID: 19112828
[TBL] [Abstract][Full Text] [Related]
8. RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.
Werner C; Baumhäkel M; Teo KK; Schmieder R; Mann J; Unger T; Yusuf S; Böhm M
Clin Res Cardiol; 2008 Jul; 97(7):418-31. PubMed ID: 18454336
[TBL] [Abstract][Full Text] [Related]
9. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
Goto K; Fujii K; Kansui Y; Iida M
Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of renin angiotensin system inhibitors in cancer cells metastasis.
Hashemzehi M; Beheshti F; Hassanian SM; Ferns GA; Khazaei M; Avan A
Pathol Res Pract; 2020 Jul; 216(7):153010. PubMed ID: 32534713
[TBL] [Abstract][Full Text] [Related]
11. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin systems.
Lee MA; Paul M; Böhm M; Ganten D
Am J Cardiol; 1992 Oct; 70(10):12C-19C. PubMed ID: 1414888
[TBL] [Abstract][Full Text] [Related]
13. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
14. Drug discovery in renin-angiotensin system intervention: past and future.
Williams B
Ther Adv Cardiovasc Dis; 2016 Jun; 10(3):118-25. PubMed ID: 27126389
[TBL] [Abstract][Full Text] [Related]
15. Renin inhibition--benefit beyond hypertension control.
Kher V
J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
[TBL] [Abstract][Full Text] [Related]
16. The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases.
Lazartigues E; Feng Y; Lavoie JL
Curr Pharm Des; 2007; 13(12):1231-45. PubMed ID: 17504232
[TBL] [Abstract][Full Text] [Related]
17. Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system.
Stegbauer J; Lee DH; Seubert S; Ellrichmann G; Manzel A; Kvakan H; Muller DN; Gaupp S; Rump LC; Gold R; Linker RA
Proc Natl Acad Sci U S A; 2009 Sep; 106(35):14942-7. PubMed ID: 19706425
[TBL] [Abstract][Full Text] [Related]
18. The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasis.
Ishikane S; Takahashi-Yanaga F
Biochem Pharmacol; 2018 May; 151():96-103. PubMed ID: 29534876
[TBL] [Abstract][Full Text] [Related]
19. The renin-angiotensin system: importance in physiology and pathology.
Ferrario CM
J Cardiovasc Pharmacol; 1990; 15 Suppl 3():S1-5. PubMed ID: 1691411
[TBL] [Abstract][Full Text] [Related]
20. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
Unger T; Gohlke P
Am J Cardiol; 1990 May; 65(19):3I-10I. PubMed ID: 2159693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
